Comerica Bank Has $5.22 Million Stock Position in Mirion Technologies, Inc. $MIR

Comerica Bank raised its holdings in Mirion Technologies, Inc. (NYSE:MIR) by 24.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 222,756 shares of the company’s stock after buying an additional 43,450 shares during the quarter. Comerica Bank’s holdings in Mirion Technologies were worth $5,217,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Advisory Services Network LLC acquired a new stake in Mirion Technologies in the 3rd quarter valued at approximately $25,000. Wolff Wiese Magana LLC acquired a new stake in Mirion Technologies in the 3rd quarter valued at approximately $26,000. Salomon & Ludwin LLC acquired a new stake in Mirion Technologies in the 3rd quarter valued at approximately $30,000. EverSource Wealth Advisors LLC grew its holdings in Mirion Technologies by 470.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,642 shares of the company’s stock valued at $35,000 after buying an additional 1,354 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its holdings in Mirion Technologies by 96.5% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,651 shares of the company’s stock valued at $38,000 after buying an additional 811 shares during the last quarter. Institutional investors and hedge funds own 78.51% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the company. Melius Research upgraded Mirion Technologies to a “strong-buy” rating in a research report on Monday, March 23rd. JPMorgan Chase & Co. reduced their price objective on Mirion Technologies from $30.00 to $27.00 and set an “overweight” rating for the company in a research report on Thursday, March 26th. The Goldman Sachs Group reduced their price objective on Mirion Technologies from $33.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, February 12th. Morgan Stanley reduced their price objective on Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating for the company in a research report on Wednesday, March 11th. Finally, Citigroup reduced their price objective on Mirion Technologies from $29.00 to $28.00 and set a “buy” rating for the company in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Mirion Technologies has an average rating of “Moderate Buy” and a consensus target price of $27.13.

Mirion Technologies Price Performance

Mirion Technologies stock opened at $19.63 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 3.19 and a quick ratio of 2.34. The company has a market capitalization of $4.92 billion, a PE ratio of 196.28 and a beta of 1.07. Mirion Technologies, Inc. has a one year low of $15.55 and a one year high of $30.28. The business has a 50 day simple moving average of $19.78 and a 200 day simple moving average of $23.17.

Mirion Technologies (NYSE:MIR) last posted its earnings results on Tuesday, April 28th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of $0.09 by $0.01. The business had revenue of $257.60 million during the quarter, compared to the consensus estimate of $244.78 million. Mirion Technologies had a return on equity of 6.44% and a net margin of 2.56%.Mirion Technologies’s revenue was up 27.5% on a year-over-year basis. During the same quarter last year, the company earned $0.10 EPS. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. On average, sell-side analysts forecast that Mirion Technologies, Inc. will post 0.51 EPS for the current fiscal year.

Mirion Technologies Company Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.